中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2010年
19期
1362-1365
,共4页
王丽君%罗蔚锋%王恒会%倪贵华%叶艳%李丹%刘春风
王麗君%囉蔚鋒%王恆會%倪貴華%葉豔%李丹%劉春風
왕려군%라위봉%왕항회%예귀화%협염%리단%류춘풍
尿酸%6-羟基多巴胺%大鼠%帕金森病%行为学%多巴胺
尿痠%6-羥基多巴胺%大鼠%帕金森病%行為學%多巴胺
뇨산%6-간기다파알%대서%파금삼병%행위학%다파알
Uric acid%6-hydroxydopamine%Rats%Behavior%Parkinson disease%Dopamine
目的 评价尿酸对6-羟基多巴胺致大鼠黑质纹状体系统多巴胺能神经元毒性的影响.方法 30只雄性SD大鼠,分为生理盐水组(10只)、100 mg/kg尿酸组(5只)、200 mg/kg尿酸组(10只)和250 mg/kg尿酸组(5只).每天2次(间隔2 h),每次腹腔注射生理盐水或尿酸5 d,于第6天第1次腹腔注射生理盐水或尿酸后,在立体定向仪指导下,右侧纹状体内两点注射6-羟基多巴胺.此后继续给予大鼠腹腔注射生理盐水或尿酸5 d.于注射6-羟基多巴胺后第3、4周分别进行自主活动计数,安非他明旋转实验,前肢功能测定.注射6-羟基多巴胺后第5周进行纹状体多巴胺和高香草酸水平测定.结果 200 mg/kg尿酸组大鼠自主活动计数[(14±4)次/2 min]明显高于生理盐水组[(4±5)次/2 min,P<0.01];安非他明诱导的旋转实验100 mg/kg尿酸组(11.2 ±4.2)和200 mg/kg尿酸组每分钟旋转次数(10.8±7.5)显著低于生理盐水组(19.3 ±5.2,P<0.01).200 mg/kg尿酸组前肢功能测定5 s内移动90 cm的前患肢步数(9.89±3.41)明显高于生理盐水组(4.36±3.72,P<0.01);200 mg/kg尿酸组毁损侧纹状体多巴胺(0.29±0.19)、高香草酸水平(1.22±0.5)显著高于生理盐水组多巴胺(0.05 ±0.03,P<0.01)、高香草酸水平(0.24±0.13,P<0.05).结论 适当提高体内的尿酸水平能减轻6-羟基多巴胺对SD大鼠黑质纹状体系统多巴胺神经元的毒性作用.
目的 評價尿痠對6-羥基多巴胺緻大鼠黑質紋狀體繫統多巴胺能神經元毒性的影響.方法 30隻雄性SD大鼠,分為生理鹽水組(10隻)、100 mg/kg尿痠組(5隻)、200 mg/kg尿痠組(10隻)和250 mg/kg尿痠組(5隻).每天2次(間隔2 h),每次腹腔註射生理鹽水或尿痠5 d,于第6天第1次腹腔註射生理鹽水或尿痠後,在立體定嚮儀指導下,右側紋狀體內兩點註射6-羥基多巴胺.此後繼續給予大鼠腹腔註射生理鹽水或尿痠5 d.于註射6-羥基多巴胺後第3、4週分彆進行自主活動計數,安非他明鏇轉實驗,前肢功能測定.註射6-羥基多巴胺後第5週進行紋狀體多巴胺和高香草痠水平測定.結果 200 mg/kg尿痠組大鼠自主活動計數[(14±4)次/2 min]明顯高于生理鹽水組[(4±5)次/2 min,P<0.01];安非他明誘導的鏇轉實驗100 mg/kg尿痠組(11.2 ±4.2)和200 mg/kg尿痠組每分鐘鏇轉次數(10.8±7.5)顯著低于生理鹽水組(19.3 ±5.2,P<0.01).200 mg/kg尿痠組前肢功能測定5 s內移動90 cm的前患肢步數(9.89±3.41)明顯高于生理鹽水組(4.36±3.72,P<0.01);200 mg/kg尿痠組燬損側紋狀體多巴胺(0.29±0.19)、高香草痠水平(1.22±0.5)顯著高于生理鹽水組多巴胺(0.05 ±0.03,P<0.01)、高香草痠水平(0.24±0.13,P<0.05).結論 適噹提高體內的尿痠水平能減輕6-羥基多巴胺對SD大鼠黑質紋狀體繫統多巴胺神經元的毒性作用.
목적 평개뇨산대6-간기다파알치대서흑질문상체계통다파알능신경원독성적영향.방법 30지웅성SD대서,분위생리염수조(10지)、100 mg/kg뇨산조(5지)、200 mg/kg뇨산조(10지)화250 mg/kg뇨산조(5지).매천2차(간격2 h),매차복강주사생리염수혹뇨산5 d,우제6천제1차복강주사생리염수혹뇨산후,재입체정향의지도하,우측문상체내량점주사6-간기다파알.차후계속급여대서복강주사생리염수혹뇨산5 d.우주사6-간기다파알후제3、4주분별진행자주활동계수,안비타명선전실험,전지공능측정.주사6-간기다파알후제5주진행문상체다파알화고향초산수평측정.결과 200 mg/kg뇨산조대서자주활동계수[(14±4)차/2 min]명현고우생리염수조[(4±5)차/2 min,P<0.01];안비타명유도적선전실험100 mg/kg뇨산조(11.2 ±4.2)화200 mg/kg뇨산조매분종선전차수(10.8±7.5)현저저우생리염수조(19.3 ±5.2,P<0.01).200 mg/kg뇨산조전지공능측정5 s내이동90 cm적전환지보수(9.89±3.41)명현고우생리염수조(4.36±3.72,P<0.01);200 mg/kg뇨산조훼손측문상체다파알(0.29±0.19)、고향초산수평(1.22±0.5)현저고우생리염수조다파알(0.05 ±0.03,P<0.01)、고향초산수평(0.24±0.13,P<0.05).결론 괄당제고체내적뇨산수평능감경6-간기다파알대SD대서흑질문상체계통다파알신경원적독성작용.
Objective To investigate the protective effects of uric acid on nigrostriatal system injury induced by 6-hydroxydopamine in rats. Methods Thirty male SD rats were divided into four groups. Uric acid of 100 mg/kg, 200 mg/kg, 250 mg/kg were injected intrapefitoneally (ip) into 5, 10, 5 rats twice daily at a 2-hour interval for five days and saline was injected ip into 10 rats as controls. At Day 6, 6hydroxydopamine was injected into striatum to establish Parkinsen's disease (PD) model in rats. Then uric acid was injected ip into three groups and saline into controls for five days. Locomotion test, amphetamineinduced rotation and forepaw adjusting step test were performed at Weeks 3 and 4 respectively after injection of 6-hydroxydopamine. HPLC-MS/MS was performed to detect the contents of dopamine and its metabolite homovanillic acid (HVA) in striatum at Week 5. Results The scores of locomotion in 2 minutes of 200 mg/kg uric acid group ( 14 ±4/2 min) was higher significantly than saline group (4±5/2 min,P <0. 01 ).The amphetamine-induced rotation number in the 200 mg/kg uric acid group (10. 8 ± 7.5 ) was lower significanfly that in the saline group ( 19. 3 ± 5.2, P < 0. 01 ). Forepaw adjusting step test scores of 200 mg/kg uric acid group were higher significantly than those in the saline group (9. 89 ±3.41 vs 4. 36±3.72,P<0.01). HPLC-MS/MS showed that the contents of DA (0.29 +0. 19) and HVA (1.22 ±0.5) in injured striatum of 200 mg/kg uric acid group were higher significantly than those in the saline group (0.05 ±0.03,P<0.01;0.24±0.13,P<0.05). Conclusion An appropriately elevated level of uric acid may protect the dopamine neuron of nigrostriatal system from injury of 6-hydroxydopamine in rats.